| MeSH | C526675 |
| PubChem Compound | 9849808 |
| BindingDB | 50248002 |
| CHEMBL | CHEMBL1201765 |
| KEGG | dr:D08923 |
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 695 Canada Vigilance: 23 | Canada Vigilance US FAERS | |
| 2 | Urinary Retention | FAERS: 283 Canada Vigilance: 19 | Canada Vigilance US FAERS | |
| 3 | Constipation | FAERS: 205 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 4 | Drug effect incomplete | FAERS: 137 | US FAERS | |
| 5 | Dizziness | FAERS: 120 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 6 | Dysuria | FAERS: 96 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 7 | Malaise | FAERS: 73 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Headache | FAERS: 64 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Urinary Incontinence | FAERS: 62 | US FAERS | |
| 10 | Nausea | FAERS: 60 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 11 | Fatigue | FAERS: 52 | US FAERS | |
| 12 | Pain | FAERS: 48 | US FAERS | |
| 13 | Somnolence | FAERS: 48 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Feeling abnormal | FAERS: 46 | US FAERS | |
| 15 | Dyspepsia | FAERS: 37 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | Nocturia | FAERS: 37 | US FAERS | |
| 17 | Urinary tract infection | FAERS: 34 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 18 | Abdominal discomfort | FAERS: 33 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 19 | Dementia | FAERS: 32 | US FAERS | |
| 20 | Abdominal Pain | FAERS: 30 | US FAERS | |
| 21 | Asthenia | FAERS: 28 | US FAERS | |
| 22 | Back Pain | FAERS: 28 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Pruritus | FAERS: 28 | US FAERS | |
| 24 | Vomiting | FAERS: 27 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 25 | Oropharyngeal pain | FAERS: 26 | US FAERS | |
| 26 | Cerebrovascular accident | FAERS: 25 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 27 | Memory impairment | FAERS: 24 | US FAERS | |
| 28 | Wrong technique in drug usage process | FAERS: 24 | US FAERS | |
| 29 | Glaucoma | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 30 | Hypersensitivity | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 31 | Alopecia | FAERS: 21 | US FAERS | |
| 32 | Dysphonia | FAERS: 21 | US FAERS | |
| 33 | Urticaria | FAERS: 21 | US FAERS | |
| 34 | Cystitis | FAERS: 19 | US FAERS | |
| 35 | Palpitations | FAERS: 19 | US FAERS | |
| 36 | Bladder pain | FAERS: 18 | US FAERS | |
| 37 | Diabetes Mellitus | FAERS: 18 | US FAERS | |
| 38 | Flatulence | FAERS: 18 | US FAERS | |
| 39 | Chest Pain | FAERS: 16 | US FAERS | |
| 40 | Hypotension | FAERS: 16 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 41 | Incorrect dose administered | FAERS: 16 | US FAERS | |
| 42 | Lip swelling | FAERS: 16 | US FAERS | |
| 43 | Nasopharyngitis | FAERS: 16 | US FAERS | |
| 44 | Product use issue | FAERS: 16 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 45 | Urine flow decreased | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 46 | Visual Impairment | FAERS: 16 | US FAERS | |
| 47 | Arthralgia | FAERS: 15 | US FAERS | |
| 48 | Dysgeusia | FAERS: 15 | US FAERS | |
| 49 | Amnesia | FAERS: 14 | US FAERS | |
| 50 | Bladder spasm | FAERS: 14 | US FAERS | |
| 51 | Discomfort | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 52 | Syncope | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 53 | Vertigo | FAERS: 14 | US FAERS | |
| 54 | Erythema | FAERS: 13 | US FAERS | |
| 55 | Tachycardia | FAERS: 13 | US FAERS | |
| 56 | Eye pain | FAERS: 12 | US FAERS | |
| 57 | Swelling | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 58 | Weight decreased | FAERS: 12 | US FAERS | |
| 59 | Blood creatinine increased | FAERS: 11 | US FAERS | |
| 60 | Blood urine present | FAERS: 11 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 61 | Drug dispensing error | FAERS: 11 | US FAERS | |
| 62 | No adverse event | FAERS: 11 | US FAERS | |
| 63 | Pneumonia | FAERS: 11 | US FAERS | |
| 64 | Tremor | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 65 | Arthropathy | FAERS: 10 | US FAERS | |
| 66 | Atrial Fibrillation | FAERS: 10 | US FAERS | |
| 67 | Blood sodium decreased | FAERS: 10 | US FAERS | |
| 68 | Dehydration | FAERS: 10 | US FAERS | |
| 69 | Diplopia | FAERS: 10 | US FAERS | |
| 70 | Incontinence | FAERS: 10 | US FAERS | |
| 71 | Thirst | FAERS: 10 | US FAERS | |
| 72 | Wrong technique in product usage process | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 73 | Angioedema | FAERS: 9 | US FAERS | |
| 74 | Anxiety | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 75 | Blood glucose increased | FAERS: 9 | US FAERS | |
| 76 | Eye irritation | FAERS: 9 | US FAERS | |
| 77 | Multiple Sclerosis | FAERS: 9 | US FAERS | |
| 78 | Tinnitus | FAERS: 9 | US FAERS | |
| 79 | nervous system disorder | FAERS: 9 | US FAERS | |
| 80 | Chest discomfort | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 81 | Dry skin | FAERS: 8 | US FAERS | |
| 82 | Intentional product misuse | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 83 | Middle insomnia | FAERS: 8 | US FAERS | |
| 84 | Product quality issue | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 85 | Product use in unapproved indication | FAERS: 8 | US FAERS | |
| 86 | Ageusia | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 87 | Blood potassium decreased | FAERS: 7 | US FAERS | |
| 88 | Bradycardia | FAERS: 7 | US FAERS | |
| 89 | Drug dose omission | FAERS: 7 | US FAERS | |
| 90 | Drug ineffective for unapproved indication | FAERS: 7 | US FAERS | |
| 91 | Expired drug administered | FAERS: 7 | US FAERS | |
| 92 | Influenza | FAERS: 7 | US FAERS | |
| 93 | Myalgia | FAERS: 7 | US FAERS | |
| 94 | Throat irritation | FAERS: 7 | US FAERS | |
| 95 | Agitation | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 96 | Arthritis | FAERS: 6 | US FAERS | |
| 97 | Blindness | FAERS: 6 | US FAERS | |
| 98 | Blood glucose decreased | FAERS: 6 | US FAERS | |
| 99 | Burning sensation | FAERS: 6 | US FAERS | |
| 100 | Expired product administered | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 101 | Infection | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 102 | Intestinal Obstruction | FAERS: 6 | US FAERS | |
| 103 | Peripheral swelling | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 104 | Therapeutic response unexpected | FAERS: 6 | US FAERS | |
| 105 | Urinary tract obstruction | FAERS: 6 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 106 | Urine output increased | FAERS: 6 | US FAERS | |
| 107 | Abasia | FAERS: 5 | US FAERS | |
| 108 | Angina Pectoris | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 109 | Angle Closure Glaucoma | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 110 | Anticholinergic Syndrome | FAERS: 5 | US FAERS | |
| 111 | Anuria | FAERS: 5 | US FAERS | |
| 112 | Aphonia | FAERS: 5 | US FAERS | |
| 113 | Back disorder | FAERS: 5 | US FAERS | |
| 114 | Bronchitis | FAERS: 5 | US FAERS | |
| 115 | Cataract | FAERS: 5 | US FAERS | |
| 116 | Crying | FAERS: 5 | US FAERS | |
| 117 | Drug effect delayed | FAERS: 5 | US FAERS | |
| 118 | Drug prescribing error | FAERS: 5 | US FAERS | |
| 119 | Eructation | FAERS: 5 | US FAERS | |
| 120 | Fracture | FAERS: 5 | US FAERS | |
| 121 | Intentional product use issue | FAERS: 5 | US FAERS | |
| 122 | Joint injury | FAERS: 5 | US FAERS | |
| 123 | Joint swelling | FAERS: 5 | US FAERS | |
| 124 | Pre-existing condition improved | FAERS: 5 | US FAERS | |
| 125 | Productive Cough | FAERS: 5 | US FAERS | |
| 126 | Renal pain | FAERS: 5 | US FAERS | |
| 127 | Wheezing | FAERS: 5 | US FAERS | |
| 128 | Accidental overdose | FAERS: 4 | US FAERS | |
| 129 | Aphasia | FAERS: 4 | US FAERS | |
| 130 | Asthma | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 131 | Blood cholesterol increased | FAERS: 4 | US FAERS | |
| 132 | Chills | FAERS: 4 | US FAERS | |
| 133 | Chromaturia | FAERS: 4 | US FAERS | |
| 134 | Delirium | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 135 | Dental caries | FAERS: 4 | US FAERS | |
| 136 | Depressed mood | FAERS: 4 | US FAERS | |
| 137 | Dysgraphia | FAERS: 4 | US FAERS | |
| 138 | Enuresis | FAERS: 4 | US FAERS | |
| 139 | Hydronephrosis | FAERS: 4 | US FAERS | |
| 140 | Hypohidrosis | FAERS: 4 | US FAERS | |
| 141 | Ileus | FAERS: 4 | US FAERS | |
| 142 | Medication Error | FAERS: 4 | US FAERS | |
| 143 | Mouth Breathing | FAERS: 4 | US FAERS | |
| 144 | Nephrolithiasis | FAERS: 4 | US FAERS | |
| 145 | Sjogren's Syndrome | FAERS: 4 | US FAERS | |
| 146 | Stomatitis | FAERS: 4 | US FAERS | |
| 147 | Stress | FAERS: 4 | US FAERS | |
| 148 | Urinary hesitation | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 149 | Anosmia | FAERS: 3 | US FAERS | |
| 150 | Aphagia | FAERS: 3 | US FAERS | |
| 151 | Blood potassium increased | FAERS: 3 | US FAERS | |
| 152 | Coronary Artery Disease | FAERS: 3 | US FAERS | |
| 153 | Cyanosis | FAERS: 3 | US FAERS | |
| 154 | Deafness | FAERS: 3 | US FAERS | |
| 155 | Ear discomfort | FAERS: 3 | US FAERS | |
| 156 | Epistaxis | FAERS: 3 | US FAERS | |
| 157 | Flushing | FAERS: 3 | US FAERS | |
| 158 | Head discomfort | FAERS: 3 | US FAERS | |
| 159 | Impaired driving ability | FAERS: 3 | US FAERS | |
| 160 | Incoherent | FAERS: 3 | US FAERS | |
| 161 | Ligament rupture | FAERS: 3 | US FAERS | |
| 162 | Loss of personal independence in daily activities | FAERS: 3 | US FAERS | |
| 163 | Macular degeneration | FAERS: 3 | US FAERS | |
| 164 | Nasal discomfort | FAERS: 3 | US FAERS | |
| 165 | Neck Pain | FAERS: 3 | US FAERS | |
| 166 | Nervousness | FAERS: 3 | US FAERS | |
| 167 | Oral pruritus | FAERS: 3 | US FAERS | |
| 168 | Presyncope | FAERS: 3 | US FAERS | |
| 169 | Pulmonary arterial hypertension | FAERS: 3 | US FAERS | |
| 170 | Reaction to drug excipients | FAERS: 3 | US FAERS | |
| 171 | Restlessness | FAERS: 3 | US FAERS | |
| 172 | Sciatica | FAERS: 3 | US FAERS | |
| 173 | Suspected counterfeit product | FAERS: 3 | US FAERS | |
| 174 | Therapeutic response changed | FAERS: 3 | US FAERS | |
| 175 | Therapy regimen changed | FAERS: 3 | US FAERS | |
| 176 | Unevaluable event | FAERS: 3 | US FAERS | |
| 177 | Acidosis | FAERS: 2 | US FAERS | |
| 178 | Activities of daily living impaired | FAERS: 2 | US FAERS | |
| 179 | Anaphylactic shock | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 180 | Atypical pneumonia | FAERS: 2 | US FAERS | |
| 181 | Bladder discomfort | FAERS: 2 | US FAERS | |
| 182 | Blood urea increased | FAERS: 2 | US FAERS | |
| 183 | Bone swelling | FAERS: 2 | US FAERS | |
| 184 | Bursitis | FAERS: 2 | US FAERS | |
| 185 | Cardiac Arrest | FAERS: 2 | US FAERS | |
| 186 | Cardiovascular insufficiency | FAERS: 2 | US FAERS | |
| 187 | Choking sensation | FAERS: 2 | US FAERS | |
| 188 | Choking | FAERS: 2 | US FAERS | |
| 189 | Conjunctivitis | FAERS: 2 | US FAERS | |
| 190 | Creatinine renal clearance decreased | FAERS: 2 | US FAERS | |
| 191 | Dependence | FAERS: 2 | US FAERS | |
| 192 | Drug withdrawal syndrome | FAERS: 2 | US FAERS | |
| 193 | Dysarthria | FAERS: 2 | US FAERS | |
| 194 | Feeling Cold | FAERS: 2 | US FAERS | |
| 195 | Fibromyalgia | FAERS: 2 | US FAERS | |
| 196 | Food Allergy | FAERS: 2 | US FAERS | |
| 197 | Frustration | FAERS: 2 | US FAERS | |
| 198 | Gastric Bypass | FAERS: 2 | US FAERS | |
| 199 | Gastritis | FAERS: 2 | US FAERS | |
| 200 | Gastrointestinal hypomotility | FAERS: 2 | US FAERS | |
| 201 | Gastrointestinal motility disorder | FAERS: 2 | US FAERS | |
| 202 | General physical health deterioration | FAERS: 2 | US FAERS | |
| 203 | Genital infection fungal | FAERS: 2 | US FAERS | |
| 204 | Genital pain | FAERS: 2 | US FAERS | |
| 205 | Genital rash | FAERS: 2 | US FAERS | |
| 206 | Hernia | FAERS: 2 | US FAERS | |
| 207 | Hypersomnia | FAERS: 2 | US FAERS | |
| 208 | Hypophagia | FAERS: 2 | US FAERS | |
| 209 | Impaired gastric emptying | FAERS: 2 | US FAERS | |
| 210 | Increased upper airway secretion | FAERS: 2 | US FAERS | |
| 211 | Inflammation | FAERS: 2 | US FAERS | |
| 212 | Large intestinal stenosis | FAERS: 2 | US FAERS | |
| 213 | Laryngitis | FAERS: 2 | US FAERS | |
| 214 | Lethargy | FAERS: 2 | US FAERS | |
| 215 | Limb discomfort | FAERS: 2 | US FAERS | |
| 216 | Lymphadenopathy | FAERS: 2 | US FAERS | |
| 217 | Mastication disorder | FAERS: 2 | US FAERS | |
| 218 | Mental impairment | FAERS: 2 | US FAERS | |
| 219 | Mood swings | FAERS: 2 | US FAERS | |
| 220 | Myocardial Infarction | FAERS: 2 | US FAERS | |
| 221 | Night sweats | FAERS: 2 | US FAERS | |
| 222 | Oropharyngeal blistering | FAERS: 2 | US FAERS | |
| 223 | Pain of skin | FAERS: 2 | US FAERS | |
| 224 | Penile Infection | FAERS: 2 | US FAERS | |
| 225 | Polyuria | FAERS: 2 | US FAERS | |
| 226 | Poor quality sleep | FAERS: 2 | US FAERS | |
| 227 | Postrenal failure | FAERS: 2 | US FAERS | |
| 228 | Product dose omission | FAERS: 2 | US FAERS | |
| 229 | Pulmonary Embolism | FAERS: 2 | US FAERS | |
| 230 | Pyelonephritis | FAERS: 2 | US FAERS | |
| 231 | Rash erythematous | FAERS: 2 | US FAERS | |
| 232 | Rectocele | FAERS: 2 | US FAERS | |
| 233 | Semen volume decreased | FAERS: 2 | US FAERS | |
| 234 | Sepsis | FAERS: 2 | US FAERS | |
| 235 | Sinusitis | FAERS: 2 | US FAERS | |
| 236 | Skin lesion | FAERS: 2 | US FAERS | |
| 237 | Skin reaction | FAERS: 2 | US FAERS | |
| 238 | Sneezing | FAERS: 2 | US FAERS | |
| 239 | Sudden death | FAERS: 2 | US FAERS | |
| 240 | Therapeutic product effect incomplete | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 241 | Thermal burn | FAERS: 2 | US FAERS | |
| 242 | Tongue spasm | FAERS: 2 | US FAERS | |
| 243 | Transaminases increased | FAERS: 2 | US FAERS | |
| 244 | Urge Incontinence | FAERS: 2 | US FAERS | |
| 245 | Acne | FAERS: 1 | US FAERS | |
| 246 | Acute kidney injury | FAERS: 1 | US FAERS | |
| 247 | Acute myocardial infarction | FAERS: 1 | US FAERS | |
| 248 | Adverse event | FAERS: 1 | US FAERS | |
| 249 | Alcohol interaction | FAERS: 1 | US FAERS | |
| 250 | Ammonia increased | FAERS: 1 | US FAERS | |
| 251 | Amnestic Disorder | FAERS: 1 | US FAERS | |
| 252 | Amphetamines positive | FAERS: 1 | US FAERS | |
| 253 | Amylase increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 254 | Anal Fissure | FAERS: 1 | US FAERS | |
| 255 | Ankle Fracture | FAERS: 1 | US FAERS | |
| 256 | Anorgasmia | FAERS: 1 | US FAERS | |
| 257 | Apparent death | FAERS: 1 | US FAERS | |
| 258 | Appendicitis | FAERS: 1 | US FAERS | |
| 259 | Bedridden | FAERS: 1 | US FAERS | |
| 260 | Benign Prostatic Hyperplasia | FAERS: 1 | US FAERS | |
| 261 | Bladder cyst | FAERS: 1 | US FAERS | |
| 262 | Bladder dysfunction | FAERS: 1 | US FAERS | |
| 263 | Bladder prolapse | FAERS: 1 | US FAERS | |
| 264 | Blepharospasm | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 265 | Blood alkaline phosphatase increased | FAERS: 1 | US FAERS | |
| 266 | Blood creatine phosphokinase increased | FAERS: 1 | US FAERS | |
| 267 | Blood glucose abnormal | FAERS: 1 | US FAERS | |
| 268 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 269 | Breast tenderness | FAERS: 1 | US FAERS | |
| 270 | Bronchospasm | FAERS: 1 | US FAERS | |
| 271 | Bruxism | FAERS: 1 | US FAERS | |
| 272 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 273 | Catheter placement | FAERS: 1 | US FAERS | |
| 274 | Cerebral Infarction | FAERS: 1 | US FAERS | |
| 275 | Cheilitis | FAERS: 1 | US FAERS | |
| 276 | Circumstance or information capable of leading to medication error | FAERS: 1 | US FAERS | |
| 277 | Cold sweat | FAERS: 1 | US FAERS | |
| 278 | Completed Suicide | FAERS: 1 | US FAERS | |
| 279 | Creatinine renal clearance increased | FAERS: 1 | US FAERS | |
| 280 | Cyst | FAERS: 1 | US FAERS | |
| 281 | Dacryostenosis acquired | FAERS: 1 | US FAERS | |
| 282 | Deafness Neurosensory | FAERS: 1 | US FAERS | |
| 283 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 284 | Depression suicidal | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 285 | Disease Progression | FAERS: 1 | US FAERS | |
| 286 | Drug administration error | FAERS: 1 | US FAERS | |
| 287 | Drug effect variable | FAERS: 1 | US FAERS | |
| 288 | Drug effective for unapproved indication | FAERS: 1 | US FAERS | |
| 289 | Drug screen false positive | FAERS: 1 | US FAERS | |
| 290 | Drug screen positive | FAERS: 1 | US FAERS | |
| 291 | Dyschezia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 292 | Dyspareunia | FAERS: 1 | US FAERS | |
| 293 | Economic problem | FAERS: 1 | US FAERS | |
| 294 | Ectopic Pregnancy | FAERS: 1 | US FAERS | |
| 295 | Eczema | FAERS: 1 | US FAERS | |
| 296 | Embolism | FAERS: 1 | US FAERS | |
| 297 | Emotional distress | FAERS: 1 | US FAERS | |
| 298 | Epigastric discomfort | FAERS: 1 | US FAERS | |
| 299 | Epilepsy | FAERS: 1 | US FAERS | |
| 300 | Erectile dysfunction | FAERS: 1 | US FAERS | |
| 301 | Erythema Multiforme | FAERS: 1 | US FAERS | |
| 302 | Escherichia infection | FAERS: 1 | US FAERS | |
| 303 | Escherichia sepsis | FAERS: 1 | US FAERS | |
| 304 | Euphoric mood | FAERS: 1 | US FAERS | |
| 305 | Extra dose administered | FAERS: 1 | US FAERS | |
| 306 | Eye Burns | FAERS: 1 | US FAERS | |
| 307 | Food Poisoning | FAERS: 1 | US FAERS | |
| 308 | Gait inability | FAERS: 1 | US FAERS | |
| 309 | Gallbladder pain | FAERS: 1 | US FAERS | |
| 310 | Gastric ulcer | FAERS: 1 | US FAERS | |
| 311 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 312 | Gout | FAERS: 1 | US FAERS | |
| 313 | Hepatitis | FAERS: 1 | US FAERS | |
| 314 | Hepatomegaly | FAERS: 1 | US FAERS | |
| 315 | Hip surgery | FAERS: 1 | US FAERS | |
| 316 | Hunger | FAERS: 1 | US FAERS | |
| 317 | Hyperacusis | FAERS: 1 | US FAERS | |
| 318 | Hyperchlorhydria | FAERS: 1 | US FAERS | |
| 319 | Hyperkeratosis | FAERS: 1 | US FAERS | |
| 320 | Hypomania | FAERS: 1 | US FAERS | |
| 321 | Hypotonic urinary bladder | FAERS: 1 | US FAERS | |
| 322 | Hypoxia | FAERS: 1 | US FAERS | |
| 323 | Impaired work ability | FAERS: 1 | US FAERS | |
| 324 | Incorrect drug administration duration | FAERS: 1 | US FAERS | |
| 325 | Infective spondylitis | FAERS: 1 | US FAERS | |
| 326 | Intentional dose omission | FAERS: 1 | US FAERS | |
| 327 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 328 | Intercepted drug prescribing error | FAERS: 1 | US FAERS | |
| 329 | Intervertebral disc disorder | FAERS: 1 | US FAERS | |
| 330 | Intraocular pressure fluctuation | FAERS: 1 | US FAERS | |
| 331 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 332 | Joint Instability | FAERS: 1 | US FAERS | |
| 333 | Joint Range of Motion Decreased | FAERS: 1 | US FAERS | |
| 334 | Laceration | FAERS: 1 | US FAERS | |
| 335 | Lactose Intolerance | FAERS: 1 | US FAERS | |
| 336 | Lip exfoliation | FAERS: 1 | US FAERS | |
| 337 | Lower respiratory tract infection | FAERS: 1 | US FAERS | |
| 338 | Lymphoma | FAERS: 1 | US FAERS | |
| 339 | Malabsorption | FAERS: 1 | US FAERS | |
| 340 | Male Orgasmic Disorder | FAERS: 1 | US FAERS | |
| 341 | Mastectomy | FAERS: 1 | US FAERS | |
| 342 | Medication residue | FAERS: 1 | US FAERS | |
| 343 | Medication residue present | FAERS: 1 | US FAERS | |
| 344 | Menorrhagia | FAERS: 1 | US FAERS | |
| 345 | Metamorphopsia | FAERS: 1 | US FAERS | |
| 346 | Migraine with Aura | FAERS: 1 | US FAERS | |
| 347 | Milk Allergy | FAERS: 1 | US FAERS | |
| 348 | Motion Sickness | FAERS: 1 | US FAERS | |
| 349 | Mouth swelling | FAERS: 1 | US FAERS | |
| 350 | Moyamoya Disease | FAERS: 1 | US FAERS | |
| 351 | Multiple System Atrophy | FAERS: 1 | US FAERS | |
| 352 | Musculoskeletal chest pain | FAERS: 1 | US FAERS | |
| 353 | Musculoskeletal discomfort | FAERS: 1 | US FAERS | |
| 354 | Myasthenia Gravis | FAERS: 1 | US FAERS | |
| 355 | Myositis | FAERS: 1 | US FAERS | |
| 356 | Nephrotic Syndrome | FAERS: 1 | US FAERS | |
| 357 | Nipple pain | FAERS: 1 | US FAERS | |
| 358 | Obesity | FAERS: 1 | US FAERS | |
| 359 | Ocular discomfort | FAERS: 1 | US FAERS | |
| 360 | Oliguria | FAERS: 1 | US FAERS | |
| 361 | Onychoclasis | FAERS: 1 | US FAERS | |
| 362 | Oropharyngeal discomfort | FAERS: 1 | US FAERS | |
| 363 | Orthostatic hypertension | FAERS: 1 | US FAERS | |
| 364 | Osteoporosis | FAERS: 1 | US FAERS | |
| 365 | Overdose | FAERS: 1 | US FAERS | |
| 366 | Overweight | FAERS: 1 | US FAERS | |
| 367 | Palliative Care | FAERS: 1 | US FAERS | |
| 368 | Pancreatitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 369 | Pelvic Pain | FAERS: 1 | US FAERS | |
| 370 | Pelvic mass | FAERS: 1 | US FAERS | |
| 371 | Peritoneal Dialysis | FAERS: 1 | US FAERS | |
| 372 | Personality Change | FAERS: 1 | US FAERS | |
| 373 | Physical assault | FAERS: 1 | US FAERS | |
| 374 | Physical product label issue | FAERS: 1 | US FAERS | |
| 375 | Pneumatosis intestinalis | FAERS: 1 | US FAERS | |
| 376 | Prescribed overdose | FAERS: 1 | US FAERS | |
| 377 | Proctitis | FAERS: 1 | US FAERS | |
| 378 | Product blister packaging issue | FAERS: 1 | US FAERS | |
| 379 | Product communication issue | FAERS: 1 | US FAERS | |
| 380 | Product label issue | FAERS: 1 | US FAERS | |
| 381 | Product lot number issue | FAERS: 1 | US FAERS | |
| 382 | Product packaging issue | FAERS: 1 | US FAERS | |
| 383 | Product physical issue | FAERS: 1 | US FAERS | |
| 384 | Proteus test positive | FAERS: 1 | US FAERS | |
| 385 | Psoriasis | FAERS: 1 | US FAERS | |
| 386 | Pyelocaliectasis | FAERS: 1 | US FAERS | |
| 387 | Rales | FAERS: 1 | US FAERS | |
| 388 | Rectal Prolapse | FAERS: 1 | US FAERS | |
| 389 | Renal cyst | FAERS: 1 | US FAERS | |
| 390 | Renal mass | FAERS: 1 | US FAERS | |
| 391 | Residual urine volume increased | FAERS: 1 | US FAERS | |
| 392 | Residual urine | FAERS: 1 | US FAERS | |
| 393 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 394 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 395 | Retching | FAERS: 1 | US FAERS | |
| 396 | Retinal Detachment | FAERS: 1 | US FAERS | |
| 397 | Scab | FAERS: 1 | US FAERS | |
| 398 | Sexual Dysfunction | FAERS: 1 | US FAERS | |
| 399 | Skin laceration | FAERS: 1 | US FAERS | |
| 400 | Sleep disorder due to general medical condition, insomnia type | FAERS: 1 | US FAERS | |
| 401 | Somnambulism | FAERS: 1 | US FAERS | |
| 402 | Spondylitis | FAERS: 1 | US FAERS | |
| 403 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 404 | Strabismus | FAERS: 1 | US FAERS | |
| 405 | Temperature intolerance | FAERS: 1 | US FAERS | |
| 406 | Tension | FAERS: 1 | US FAERS | |
| 407 | Terminal state | FAERS: 1 | US FAERS | |
| 408 | Therapeutic product effect delayed | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 409 | Thrombocytopenia | FAERS: 1 | US FAERS | |
| 410 | Thrombosis | FAERS: 1 | US FAERS | |
| 411 | Tongue blistering | FAERS: 1 | US FAERS | |
| 412 | Tongue exfoliation | FAERS: 1 | US FAERS | |
| 413 | Tooth Extraction | FAERS: 1 | US FAERS | |
| 414 | Tooth Loss | FAERS: 1 | US FAERS | |
| 415 | Toothache | FAERS: 1 | US FAERS | |
| 416 | Troponin increased | FAERS: 1 | US FAERS | |
| 417 | Urethral Stenosis | FAERS: 1 | US FAERS | |
| 418 | Urethritis noninfective | FAERS: 1 | US FAERS | |
| 419 | Urinary Tract Pain | FAERS: 1 | US FAERS | |
| 420 | Vaginal lesion | FAERS: 1 | US FAERS | |
| 421 | Vasculitis | FAERS: 1 | US FAERS | |
| 422 | Viral upper respiratory tract infection | FAERS: 1 | US FAERS | |
| 423 | Vitreous floaters | FAERS: 1 | US FAERS | |
| 424 | Vocal Cord Paralysis | FAERS: 1 | US FAERS | |
| 425 | Vulvovaginal discomfort | FAERS: 1 | US FAERS | |
| 426 | Vulvovaginal dryness | FAERS: 1 | US FAERS | |
| 427 | Vulvovaginal pain | FAERS: 1 | US FAERS | |
| 428 | Vulvovaginal pruritus | FAERS: 1 | US FAERS | |
| 429 | Walking aid user | FAERS: 1 | US FAERS | |
| 430 | White blood cell count abnormal | FAERS: 1 | US FAERS | |
| 431 | White blood cell count decreased | FAERS: 1 | US FAERS | |
| 432 | Xerophthalmia | FAERS: 1 | US FAERS | |
| 433 | prostatitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 434 | pseudomembranous colitis | FAERS: 1 | US FAERS | |
| 435 | Accidental exposure to product | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.